Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Transplantation

Free Subscription Articles published in Hepatology Retrieve available abstracts of 70 articles: HTML format

Single Articles

September 2025
1. GRADY J, Arab JP
   Honey, I shrunk the tumor: Downstaging HCC before liver transplantation.
   Hepatology. 2025;82:541-542.
   PubMed    
   
   
   May 2025
2. ZHAO M, Zhang Y, Zhao J
   Letter to the editor: Considerations on the use of the liver transplant comorbidity index (LTCI).
   Hepatology. 2025 May 29. doi: 10.1097/HEP.0000000000001413.
   PubMed    
   
   
   
3. WANG P, Zhong L
   Letter to the editor: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment.
   Hepatology. 2025 May 1. doi: 10.1097/HEP.0000000000001373.
   PubMed    
   
   
   April 2025
4. MOECKLI B, Lanz L, Rodriguez-Peralvarez M, Lacotte S, et al
   Reply: Antibody-mediated rejection in liver transplantation following immune checkpoint inhibitors treatment.
   Hepatology. 2025 Apr 29. doi: 10.1097/HEP.0000000000001375.
   PubMed    
   
   
   
5. ZHANG Y
   Letter to the Editor: Dynamic frailty trajectories and temporal measurement challenges in assessing Liver Transplantation survival benefit.
   Hepatology. 2025 Apr 21. doi: 10.1097/HEP.0000000000001358.
   PubMed    
   
   
   
6. GOLDBERG D, Blandon C, Delgado C, John B, et al
   Simulating the impact of survival benefit-based liver transplant organ allocation.
   Hepatology. 2025 Apr 4. doi: 10.1097/HEP.0000000000001338.
   PubMed     Abstract available
   
   
   
7. SIDHU G
   From Frail to Free: How Liver Transplantation Defies Frailty's Limits.
   Hepatology. 2025;81:1107-1108.
   PubMed    
   
   
   
8. NOBEL YR, Boike JR, Mazumder NR, Thornburg B, et al
   Predictors of long-term clinical outcomes after TIPS: An ALTA group study.
   Hepatology. 2025;81:1244-1255.
   PubMed     Abstract available
   
   
   March 2025
9. CHAPMAN B, Wong D, Sinclair M, Hey P, et al
   Reply: Targeted enteral feeding for malnutrition in Liver Transplant candidates.
   Hepatology. 2025 Mar 25. doi: 10.1097/HEP.0000000000001319.
   PubMed    
   
   
   
10. LAI JC, Shui AM, Molinari M, Rahimi R, et al
    The Liver Transplant Comorbidity Index (LTCI) : A composite index of ambulatory Pre-LT factors to identify patients at increased risk of Post-LT Mortality.
    Hepatology. 2025 Mar 25. doi: 10.1097/HEP.0000000000001320.
    PubMed     Abstract available
    
    
    
11. CHEN Q
    Letter to the Editor: targeted enteral feeding for malnutrition in liver transplant candidates.
    Hepatology. 2025 Mar 24. doi: 10.1097/HEP.0000000000001317.
    PubMed    
    
    
    
12. WANG P, Zhong L
    Letter to the Editor: Downstaging of hepatocellular carcinoma before liver transplantation: More details, more significance.
    Hepatology. 2025 Mar 10. doi: 10.1097/HEP.0000000000001301.
    PubMed    
    
    
    
13. XU E, Mehta N
    Reply: Downstaging of hepatocellular carcinoma before liver transplantation.
    Hepatology. 2025 Mar 10. doi: 10.1097/HEP.0000000000001303.
    PubMed    
    
    
    
14. MOECKLI B, Wassmer CH, El Hajji S, Kumar R, et al
    Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.
    Hepatology. 2025 Mar 5. doi: 10.1097/HEP.0000000000001289.
    PubMed     Abstract available
    
    
    
15. ZHANG S, Sun Z, Chen Z, Bi Y, et al
    Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury.
    Hepatology. 2025;81:888-902.
    PubMed     Abstract available
    
    
    February 2025
16. WU C, Zhou Y, Mu Y, Hong W, et al
    Letter to the editor: Liver transplantation for primary and secondary liver tumours-patient-level meta-analyses compared to UNOS conventional indications.
    Hepatology. 2025 Feb 18. doi: 10.1097/HEP.0000000000001270.
    PubMed    
    
    
    
17. CIRIA R, Aliseda D, Berardi G, Rotellar F, et al
    Reply: Liver transplantation for primary and secondary liver tumors - patient level meta-analyses compared to UNOS conventional indications.
    Hepatology. 2025 Feb 18. doi: 10.1097/HEP.0000000000001272.
    PubMed    
    
    
    
18. CANCADO GGL, Deeb M, Gulamhusein AF
    Liver transplantation for cholestatic liver diseases: Timing & disease recurrence.
    Hepatology. 2025 Feb 17. doi: 10.1097/HEP.0000000000001268.
    PubMed     Abstract available
    
    
    January 2025
19. XU E, Tabrizian P, Gutierrez J, Hoteit M, et al
    Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multi-center prospective cohort study.
    Hepatology. 2025 Jan 14. doi: 10.1097/HEP.0000000000001231.
    PubMed     Abstract available
    
    
    December 2024
20. BROOKHART MA, Mayne TJ, Coombs C, Breskin A, et al
    Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design.
    Hepatology. 2024 Dec 2. doi: 10.1097/HEP.0000000000001174.
    PubMed     Abstract available
    
    
    
21. MULLISH BH, Thursz MR
    Alcohol-associated liver disease: Emerging therapeutic strategies.
    Hepatology. 2024;80:1372-1389.
    PubMed     Abstract available
    
    
    
22. ABERG F, Jiang ZG, Cortez-Pinto H, Mannisto V, et al
    Alcohol-associated liver disease-Global epidemiology.
    Hepatology. 2024;80:1307-1322.
    PubMed     Abstract available
    
    
    November 2024
23. MOECKLI B, Rodrigues Ribeiro J, Toso C
    Liver transplantation for nonstandard oncological indications: Are we there yet?
    Hepatology. 2024 Nov 4. doi: 10.1097/HEP.0000000000001131.
    PubMed    
    
    
    October 2024
24. CIRIA R, Ivanics T, Aliseda D, Claasen M, et al
    Liver transplantation for primary and secondary liver tumours. patient-level meta-analyses compared to unos conventional indications.
    Hepatology. 2024 Oct 28. doi: 10.1097/HEP.0000000000001129.
    PubMed     Abstract available
    
    
    September 2024
25. 
    Developing Quality Measures for Improving Pre-Liver Transplant Care.
    Hepatology. 2024;80:740-741.
    PubMed    
    
    
    July 2024
26. WANG M, Chiou SH, Ganger D, Ruck J, et al
    Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study.
    Hepatology. 2024 Jul 24. doi: 10.1097/HEP.0000000000001030.
    PubMed     Abstract available
    
    
    
27. 
    Developing Quality Measures for Improving Pre-Liver Transplant Care.
    Hepatology. 2024 Jul 17. doi: 10.1097/HEP.0000000000001011.
    PubMed    
    
    
    
28. NEIL DAH, Smith ML, Minervini M, Demetris AJ, et al
    Reply: Additional viewpoints from transplant surgeons on Banff consensus recommendations for the assessment of steatotic donor livers.
    Hepatology. 2024;80:E6-E7.
    PubMed    
    
    
    
29. CAO H, Gu J
    Letter to the Editor: Additional viewpoints from transplant surgeons on Banff consensus recommendations for the assessment of steatotic donor livers.
    Hepatology. 2024;80:E4-E5.
    PubMed    
    
    
    June 2024
30. SIMONETTO DA, Winder GS, Connor AA, Terrault NA, et al
    Liver transplantation for Alcohol-associated liver disease.
    Hepatology. 2024 Jun 18. doi: 10.1097/HEP.0000000000000978.
    PubMed     Abstract available
    
    
    
31. UMBAUGH DS, Nguyen NT, Curry SC, Rule JA, et al
    The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure.
    Hepatology. 2024;79:1352-1364.
    PubMed     Abstract available
    
    
    May 2024
32. LENZ D, Schlieben LD, Shimura M, Bianzano A, et al
    Genetic landscape of pediatric acute liver failure of indeterminate origin.
    Hepatology. 2024;79:1075-1087.
    PubMed     Abstract available
    
    
    April 2024
33. OCHOA-ALLEMANT P, Serper M, Wang RX, Tang H, et al
    Waitlisting and liver transplantation for MetALD in the United States: An analysis of the UNOS national registry.
    Hepatology. 2024 Apr 29. doi: 10.1097/HEP.0000000000000914.
    PubMed     Abstract available
    
    
    March 2024
34. CRUZ C, Prado CM, Gillis C, Martindale R, et al
    Nutritional aspects of prehabilitation in adults with cirrhosis awaiting liver transplant.
    Hepatology. 2024 Mar 28. doi: 10.1097/HEP.0000000000000818.
    PubMed     Abstract available
    
    
    
35. FENG S, Roll GR, Rouhani FJ, Sanchez Fueyo A, et al
    The future of Liver Transplantation.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000873.
    PubMed     Abstract available
    
    
    
36. BRAHMANIA M, Kuo A, Tapper EB, Volk M, et al
    Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.
    Hepatology. 2024 Mar 27. doi: 10.1097/HEP.0000000000000870.
    PubMed     Abstract available
    
    
    
37. CHAPMAN B, Wong D, Sinclair M, Hey P, et al
    Reversing malnutrition and low muscle strength with targeted enteral feeding in patients awaiting liver transplant: A randomized controlled trial.
    Hepatology. 2024 Mar 8. doi: 10.1097/HEP.0000000000000840.
    PubMed     Abstract available
    
    
    
38. LAL BB, Alam S, Sibal A, Kumar K, et al
    Genotype correlates with clinical course and outcome of children with tight junction protein 2 (TJP2) deficiency-related cholestasis.
    Hepatology. 2024 Mar 6. doi: 10.1097/HEP.0000000000000828.
    PubMed     Abstract available
    
    
    
39. CZIGANY Z, Putri AJ, Michalski CW, Mehrabi A, et al
    Letter to the editor: Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOTTM): A randomized, open-label, clinical trial.
    Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000811.
    PubMed    
    
    
    
40. LUNSFORD KE, Panayotova G, Guarrera JV
    Response to Letter to the Editor on portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOT).
    Hepatology. 2024 Mar 5. doi: 10.1097/HEP.0000000000000815.
    PubMed    
    
    
    
41. FLORES CARVALHO M, Boteon YL, Guarrera JV, Modi PR, et al
    Obstacles to implement machine perfusion technology in routine clinical practice of transplantation: Why are we not there yet?
    Hepatology. 2024;79:713-730.
    PubMed     Abstract available
    
    
    February 2024
42. DONGELMANS E, Erler N, Adam R, Nadalin S, et al
    Recent outcomes of liver transplantation for Budd Chiari Syndrome - a study of the European Liver Transplant Registry (ELTR) and affiliated centers.
    Hepatology. 2024 Feb 15. doi: 10.1097/HEP.0000000000000778.
    PubMed     Abstract available
    
    
    
43. BARR RG, Bolondi L
    Contrast-enhanced US for HCC: Finally out from the waiting list?
    Hepatology. 2024;79:267-268.
    PubMed    
    
    
    December 2023
44. PANAYOTOVA GG, Lunsford KE, Quillin RC 3rd, Rana A, et al
    Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOTTM): A randomized, open-label, clinical trial.
    Hepatology. 2023 Dec 13. doi: 10.1097/HEP.0000000000000715.
    PubMed     Abstract available
    
    
    
45. SIDDIQUI MS, Muthiah M, Satapathy SK, Patidar K, et al
    Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantation.
    Hepatology. 2023 Dec 13. doi: 10.1097/HEP.0000000000000720.
    PubMed     Abstract available
    
    
    
46. YU S, Liu X, Xu Y, Pan L, et al
    m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury.
    Hepatology. 2023 Dec 12. doi: 10.1097/HEP.0000000000000716.
    PubMed     Abstract available
    
    
    November 2023
47. VAN DER MEEREN PE, Frederik de Wilde R, Sprengers D, IJzermans JNM, et al
    Benefit and harm of waiting time in liver transplantation for HCC.
    Hepatology. 2023 Nov 16. doi: 10.1097/HEP.0000000000000668.
    PubMed     Abstract available
    
    
    
48. D'AMICO G, Zipprich A, Villanueva C, Sorda JA, et al
    Further decompensation in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements.
    Hepatology. 2023 Nov 2. doi: 10.1097/HEP.0000000000000652.
    PubMed     Abstract available
    
    
    October 2023
49. MASPERO M, Hashimoto K, Fairchild RL, Schlegel A, et al
    Reply: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 Oct 9. doi: 10.1097/HEP.0000000000000630.
    PubMed    
    
    
    
50. TANG G, Zhang L, Zhou R
    Letter to the Editor: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 Oct 9. doi: 10.1097/HEP.0000000000000624.
    PubMed    
    
    
    
51. MASPERO M, Hashimoto K, Fairchild RL, Schlegel A, et al
    Reply: Acute rejection after transplantation of machine perfused livers-We have barely scratched the surface.
    Hepatology. 2023;78:E69-E71.
    PubMed    
    
    
    
52. STRAVITZ RT, Fontana RJ, Karvellas C, Durkalski V, et al
    Future directions in acute liver failure.
    Hepatology. 2023;78:1266-1289.
    PubMed     Abstract available
    
    
    September 2023
53. ZHAO X, Kotha S, Nayyar D, Ma X, et al
    Physiologic changes in the hepatopulmonary syndrome before and after liver transplant: A longitudinal and predictor analysis.
    Hepatology. 2023 Sep 21. doi: 10.1097/HEP.0000000000000605.
    PubMed     Abstract available
    
    
    
54. SLOOTER CD, van den Brand FF, Lleo A, Colapietro F, et al
    Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry.
    Hepatology. 2023 Sep 4. doi: 10.1097/HEP.0000000000000589.
    PubMed     Abstract available
    
    
    
55. WU WK, Alexopoulos SP, Bacchetta M
    Reply: Xenogeneic cross-circulation of ex vivo human livers or liver xenotransplantation?
    Hepatology. 2023;78:E50-E51.
    PubMed    
    
    
    
56. EKSER B
    Letter to the Editor: Xenogeneic cross-circulation of ex vivo human livers or liver xenotransplantation?
    Hepatology. 2023;78:E48-E49.
    PubMed    
    
    
    
57. WU WK, Ukita R, Patel YJ, Cortelli M, et al
    Xenogeneic cross-circulation for physiological support and recovery of ex vivo human livers.
    Hepatology. 2023;78:820-834.
    PubMed     Abstract available
    
    
    June 2023
58. MASPERO M, Hashimoto K, Fairchild RL, Schlegel A, et al
    Reply: Acute rejection in liver transplantation: Time for uniform definitions.
    Hepatology. 2023 Jun 5. doi: 10.1097/HEP.0000000000000500.
    PubMed    
    
    
    
59. GU Y, Yu T, Xiang Y
    Letter to the Editor: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 Jun 5. doi: 10.1097/HEP.0000000000000499.
    PubMed    
    
    
    
60. EKSER B, Sucu S, Mihaylov P, Emamaullee JA, et al
    Letter to the Editor mucosal gut microbiota in primary sclerosing cholangitis before and after liver transplantation: Are there other challenges?
    Hepatology. 2023 Jun 5. doi: 10.1097/HEP.0000000000000503.
    PubMed    
    
    
    May 2023
61. LIANG A, Jia J, Zhong K, Nie Y, et al
    Letter to the editor: Acute rejection after liver transplantation with machine perfusion versus static cold storage: A systematic review and meta-analysis.
    Hepatology. 2023 May 26. doi: 10.1097/HEP.0000000000000482.
    PubMed    
    
    
    
62. TONON M, Balcar L, Semmler G, Calvino V, et al
    Etiological cure prevents further decompensation and mortality in cirrhotic patients with ascites as the single first decompensating event.
    Hepatology. 2023 May 17. doi: 10.1097/HEP.0000000000000460.
    PubMed     Abstract available
    
    
    
63. MEHTA N, Kelley RK, Yao FY
    Refining the approach to down-staging for hepatocellular carcinoma prior to liver transplantation: Patient selection, local-regional treatments, and systemic therapies.
    Hepatology. 2023 May 16. doi: 10.1097/HEP.0000000000000452.
    PubMed    
    
    
    
64. MALLET M, Silaghi CA, Sultanik P, Conti F, et al
    Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis.
    Hepatology. 2023 May 16. doi: 10.1097/HEP.0000000000000456.
    PubMed     Abstract available
    
    
    
65. FORMAN LM, Sapisochin G, Assis DN, Arrive L, et al
    Reply: Living donor liver transplantation for people with PSC.
    Hepatology. 2023;77:E97-E98.
    PubMed    
    
    
    
66. AHMED A, Arshad MW, Ibrahim H
    Letter to the editor: Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis.
    Hepatology. 2023 May 1. doi: 10.1097/HEP.0000000000000429.
    PubMed    
    
    
    
67. CULLARO G
    Reply: Variability in serum creatinine is associated with waitlist and post-liver transplant mortality in patients with cirrhosis.
    Hepatology. 2023 May 1. doi: 10.1097/HEP.0000000000000434.
    PubMed    
    
    
    April 2023
68. SONG Z, Han H, Ge X, Das S, et al
    Deficiency of neutrophil high-mobility group box protein-1, in liver transplant recipients, exacerbates early allograft injury in mice.
    Hepatology. 2023 Apr 6. doi: 10.1097/HEP.0000000000000346.
    PubMed     Abstract available
    
    
    March 2023
69. MASPERO M, Ali K, Cazzaniga B, Yilmaz S, et al
    Acute rejection after liver transplantation with machine perfusion versus static cold storage: a systematic review and meta-analysis.
    Hepatology. 2023 Mar 30. doi: 10.1097/HEP.0000000000000363.
    PubMed     Abstract available
    
    
    
70. KWONG AJ, Zhang KY, Ebel N, Mannalithara A, et al
    MELD 3.0 for adolescent liver transplant candidates.
    Hepatology. 2023 Mar 22. doi: 10.1097/HEP.0000000000000352.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Transplantation is free of charge.